Association of cardiovascular disease with 30-day hospital readmission in Chinese patients receiving maintenance dialysis.
30-day hospital readmission
Cardiovascular disease (CVD)
China
dialysis
Journal
Annals of translational medicine
ISSN: 2305-5839
Titre abrégé: Ann Transl Med
Pays: China
ID NLM: 101617978
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
entrez:
14
5
2021
pubmed:
15
5
2021
medline:
15
5
2021
Statut:
ppublish
Résumé
Previous studies have shown cardiovascular disease (CVD) to be a risk factor in the prediction of 30-day hospital readmission among patients receiving dialysis. However, studies of Asian populations are limited. In the present study, we examined the association between CVD and 30-day hospital readmission in Chinese patients receiving maintenance dialysis. Patients receiving maintenance dialysis were identified by searching a national claims database, the China Health Insurance Research Association (CHIRA) database, using the International Classification of Diseases revision 10 (ICD-10) and items of medical service claims. Patients aged ≥18 years who were discharged after index hospitalization between January 2015 and December 2015 were included in our retrospective analysis. CVD-related diagnoses were divided into three categories: coronary heart disease (CHD), heart failure (HF), and stroke. Thirty-day hospital readmission was defined as any hospital readmission within the 30 days following discharge. Logistic regression models adjusted for logit of propensity scores (PS) were used to assess the association of CVD with 30-day hospital readmission. Of 4,700 patients receiving dialysis, the 30-day hospital readmission rate was 10.4%. Compared with patients without CVD, there was an increased risk of 30-day hospital readmission among maintenance dialysis patients with total CVD [odds ratio (OR): 1.33, 95% confidence interval (CI): 1.06-1.66]. Patients with HF (OR: 1.77, CI: 1.27-2.47) and stroke (OR: 2.14, 95% CI: 1.53-2.98) had a greater risk of 30-day hospital readmission. The fully adjusted OR of CHD for the risk of 30-day hospital readmission was 1.22 (95% CI: 0.97-1.55). CVDs, especially stroke and HF, are independent predictors of 30-day hospital readmission in Chinese patients receiving dialysis, and could help to guide interventions to improve the quality of care for these patients.
Sections du résumé
BACKGROUND
BACKGROUND
Previous studies have shown cardiovascular disease (CVD) to be a risk factor in the prediction of 30-day hospital readmission among patients receiving dialysis. However, studies of Asian populations are limited. In the present study, we examined the association between CVD and 30-day hospital readmission in Chinese patients receiving maintenance dialysis.
METHODS
METHODS
Patients receiving maintenance dialysis were identified by searching a national claims database, the China Health Insurance Research Association (CHIRA) database, using the International Classification of Diseases revision 10 (ICD-10) and items of medical service claims. Patients aged ≥18 years who were discharged after index hospitalization between January 2015 and December 2015 were included in our retrospective analysis. CVD-related diagnoses were divided into three categories: coronary heart disease (CHD), heart failure (HF), and stroke. Thirty-day hospital readmission was defined as any hospital readmission within the 30 days following discharge. Logistic regression models adjusted for logit of propensity scores (PS) were used to assess the association of CVD with 30-day hospital readmission.
RESULTS
RESULTS
Of 4,700 patients receiving dialysis, the 30-day hospital readmission rate was 10.4%. Compared with patients without CVD, there was an increased risk of 30-day hospital readmission among maintenance dialysis patients with total CVD [odds ratio (OR): 1.33, 95% confidence interval (CI): 1.06-1.66]. Patients with HF (OR: 1.77, CI: 1.27-2.47) and stroke (OR: 2.14, 95% CI: 1.53-2.98) had a greater risk of 30-day hospital readmission. The fully adjusted OR of CHD for the risk of 30-day hospital readmission was 1.22 (95% CI: 0.97-1.55).
CONCLUSIONS
CONCLUSIONS
CVDs, especially stroke and HF, are independent predictors of 30-day hospital readmission in Chinese patients receiving dialysis, and could help to guide interventions to improve the quality of care for these patients.
Identifiants
pubmed: 33987315
doi: 10.21037/atm-20-2367
pii: atm-09-08-617
pmc: PMC8106029
doi:
Types de publication
Journal Article
Langues
eng
Pagination
617Informations de copyright
2021 Annals of Translational Medicine. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/atm-20-2367). RC, CY, HC, JW, BG, LL, YJ, YL, JW, GK, FW, LZ, and M Zhao report grants from the National Natural Science Foundation of China, Peking University, the Ministry of Science and Technology of the People’s Republic of China, the University of Michigan Health System-Peking University Health Science Center Joint Institute for Translational and Clinical Research, and Peking University First Hospital. The other author has no conflicts of interest to declare.
Références
Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2311-6
pubmed: 21084697
Blood. 2010 Dec 2;116(23):4754-61
pubmed: 20826717
Nat Med. 2011 Jul 07;17(7):796-808
pubmed: 21738161
JAMA Intern Med. 2015 Nov;175(11):1803-12
pubmed: 26368317
Kidney Int Suppl (2011). 2019 Mar;9(1):e1-e81
pubmed: 30828481
J Am Soc Nephrol. 2015 Dec;26(12):3141-50
pubmed: 25855772
Am J Kidney Dis. 2019 Mar;73(3 Suppl 1):A7-A8
pubmed: 30798791
Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1652-1662
pubmed: 28971982
Clin Kidney J. 2017 Aug;10(4):552-559
pubmed: 28852495
Circulation. 2003 Jan 21;107(2):226-9
pubmed: 12538419
Health Econ Policy Law. 2014 Apr;9(2):193-213
pubmed: 23987089
Front Immunol. 2019 Apr 02;10:686
pubmed: 31001280
Kidney Int. 2017 Oct;92(4):934-941
pubmed: 28532710
Cell. 2001 Feb 23;104(4):503-16
pubmed: 11239408
Perit Dial Int. 2019 May-Jun;39(3):261-267
pubmed: 30846608
N Engl J Med. 2016 Apr 21;374(16):1543-51
pubmed: 26910198
J Am Soc Nephrol. 2001 Nov;12(11):2465-2473
pubmed: 11675424
Cell. 2011 Apr 29;145(3):341-55
pubmed: 21529710
Ann Fam Med. 2009 Jul-Aug;7(4):357-63
pubmed: 19597174
Biometrics. 1996 Mar;52(1):249-64
pubmed: 8934595
N Engl J Med. 2009 Apr 2;360(14):1418-28
pubmed: 19339721
Eur J Gen Pract. 2018 Dec;24(1):45-50
pubmed: 29168400
J Am Heart Assoc. 2018 Feb 13;7(4):
pubmed: 29440035
J Am Soc Nephrol. 2014 Sep;25(9):2079-87
pubmed: 24812168
Eur Heart J. 2005 Nov;26(21):2232-7
pubmed: 15987710